Immunogen Inc. buy BMO Capital Markets
Start price
01.08.23
/
50%
€16.22
Target price
01.08.24
€23.69
Performance (%)
78.61%
End price
02.08.24
-
Summary
This prediction is currently being closed. The BUY prediction by BMO_Capital_Markets for Immunogen Inc. has seen massive gains of 78.61%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunogen Inc. | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by BMO_Capital_Markets for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at BMO Capital Markets from $25.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten